Ziopharm Oncology Inc – ‘10-Q’ for 9/30/12

On:  Thursday, 11/8/12, at 4:12pm ET   ·   For:  9/30/12   ·   Accession #:  1144204-12-60430   ·   File #:  1-33038

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    364K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
31: R1          Document and Entity Information                     HTML     37K 
22: R2          Balance Sheets                                      HTML    112K 
29: R3          Balance Sheets (Parenthetical)                      HTML     39K 
34: R4          Statements Of Operations                            HTML     67K 
46: R5          Statement Of Stockholders' Equity                   HTML     74K 
23: R6          Statement Of Stockholders' Equity (Parenthetical)   HTML     18K 
28: R7          Statements of Cash Flows                            HTML    142K 
20: R8          Business                                            HTML     29K 
14: R9          Summary of Significant Accounting Policies          HTML     21K 
47: R10         Restructuring                                       HTML     21K 
36: R11         Fair Value Measurements                             HTML     39K 
35: R12         Net Loss per Share                                  HTML     24K 
40: R13         Related Party Transactions                          HTML     24K 
41: R14         Commitments and Contingencies                       HTML     52K 
39: R15         Warrants                                            HTML     52K 
42: R16         Common Stock                                        HTML     20K 
30: R17         Stock-Based Compensation                            HTML     50K 
33: R18         Fair Value Measurements (Tables)                    HTML     28K 
38: R19         Net Loss per Share (Tables)                         HTML     23K 
50: R20         Warrants (Tables)                                   HTML     43K 
44: R21         Stock-Based Compensation (Tables)                   HTML     52K 
25: R22         Business - Additional Information (Detail)          HTML     23K 
37: R23         Restructuring (Additional Information) (Detail)     HTML     18K 
27: R24         Assets and Liabilities Measured at Fair Value on    HTML     26K 
                Recurring Basis (Detail)                                         
12: R25         Potential Dilutive Shares Excluded from             HTML     26K 
                Computation of Diluted Net Loss Per Share (Detail)               
45: R26         Related Party Transactions - Additional             HTML     28K 
                Information (Detail)                                             
48: R27         Commitments and Contingencies - Additional          HTML    111K 
                Information (Detail)                                             
17: R28         Number of Warrants Outstanding (Detail)             HTML     21K 
16: R29         Warrants - Additional Information (Detail)          HTML     74K 
18: R30         Assumptions Used In Binomial Valuation Model and    HTML     25K 
                Black-Scholes Valuation Model (Detail)                           
19: R31         Warrant Exercise (Detail)                           HTML     32K 
21: R32         Common Stock - Additional Information (Detail)      HTML     34K 
11: R33         Stock-Based Compensation Expense on All Employee    HTML     23K 
                and Non-Employee Awards (Detail)                                 
43: R34         Stock-Based Compensation - Additional Information   HTML     48K 
                (Detail)                                                         
24: R35         Fair Value of Stock Options Assumptions Using       HTML     34K 
                Black-Scholes Option Valuation Model (Detail)                    
26: R36         Stock Option Activity Under Stock Option Plan       HTML     81K 
                (Detail)                                                         
13: R37         Summary of Unvested Restricted Stock (Detail)       HTML     46K 
49: XML         IDEA XML File -- Filing Summary                      XML     75K 
15: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    383K 
 5: EX-101.INS  XBRL Instance -- ziop-20120930                       XML    722K 
 7: EX-101.CAL  XBRL Calculations -- ziop-20120930_cal               XML     78K 
 8: EX-101.DEF  XBRL Definitions -- ziop-20120930_def                XML    564K 
 9: EX-101.LAB  XBRL Labels -- ziop-20120930_lab                     XML   1.10M 
10: EX-101.PRE  XBRL Presentations -- ziop-20120930_pre              XML    642K 
 6: EX-101.SCH  XBRL Schema -- ziop-20120930                         XSD    153K 
32: ZIP         XBRL Zipped Folder -- 0001144204-12-060430-xbrl      Zip     92K 

        

To view the SGML, please refresh this page.